Related Experiment Video

Updated: Jun 4, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

[Transcatheter aortic-valve implantation for aortic stenosis. An established procedure?]

H R Figulla1, M Ferrari

  • 1Klinik für Innere Medizin I, Universitätsherzzentrum Jena, Erlanger Allee 101, 07747, Jena, Deutschland. Hans.Figulla@med.uni-jena.de

Herz
|February 18, 2011
PubMed

Insights

Transcatheter aortic-valve implantation (TAVI) is increasingly used for aortic stenosis in aging populations. However, TAVI is not yet considered established due to unproven safety and efficiency compared to surgery.

Area of Science:

  • Cardiology
  • Medical Technology
  • Geriatrics

Context:

  • Aging populations in Western countries face rising cases of severe aortic stenosis.
  • Historically, many symptomatic patients were not candidates for aortic valve replacement, facing poor survival rates with conservative treatment.
  • Transcatheter aortic-valve implantation (TAVI) is increasingly utilized in Germany, with established reimbursement and guidelines.

Purpose:

  • To evaluate the established status of Transcatheter Aortic Valve Implantation (TAVI) in Germany.
  • To assess the safety, efficiency, and economic viability of TAVI compared to surgical aortic valve replacement.
  • To determine the need for alternative treatments for aortic stenosis in the elderly.

Summary:

  • Despite widespread use and reimbursement in Germany, TAVI is not formally established as a treatment modality.
  • Establishment requires proven safety and efficiency via randomized trials, which are currently lacking for TAVI compared to surgical intervention.
  • The economic impact of TAVI remains unclear, though there is a clear demand for alternatives to surgery in the aging demographic.

Impact:

  • Highlights the gap between TAVI's clinical adoption and regulatory definition of an 'established' treatment.
  • Underscores the need for rigorous comparative effectiveness research to validate TAVI's role in managing aortic stenosis.
  • Emphasizes the ongoing search for safer, more accessible treatments for the growing elderly population with aortic stenosis.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...